PULMOCIDE LIMITED
No Analysis Available
Get instant AI-powered insights about this company's financial health, risks, and trends.
Order Analysis - £10- Legal registered address
- Office Suite 3.01 44 Southampton Buildings London England WC2A 1AP Copied!
Latest financial results as of 14 September 2025- Cash in bank
- £35.51m
- Current assets
- £40.13m
- Fixed assets
- £431.72k
- Current creditors
- £3.27m
- Shareholders funds
- £95.56m
View full financial accounts- Cash in bank
- £35.51m
- Current assets
- £40.13m
- Fixed assets
- £431.72k
- Current creditors
- £3.27m
- Shareholders funds
- £95.56m
Current company directors
BHAMAN, MAINA
BINGHAM, Catherine Elizabeth, Dame
BOLGER, JEANNE ELIZABETH
BURGESS, Daniel Dean
FINCH, HARRY
FOY, Matthew James
KNIGHT, Stephen Christian
MASH, Fiona Caroline, Dr
MEYERS, James Robert
NUNN, Jason Raleigh
PASTEUR, Alexander Thomas
RAPEPORT, WILLIAM GARTH
STRONG, PETER
STRONG, PETER
View full details of company directors- Company number
- 06182024 Copied!
Accounts
Latest annual accounts were to 31 December 2024
Next annual accounts are due by 30 September 2026
Company financial year end is on 31 December 2025
Confirmation statement
Latest confirmation statement statement dated 30 April 2025
Next statement due by 14 May 2026
Nature of business (SIC)
72110 - Research and experimental development on biotechnology
Latest company documents
Date | Description |
---|---|
29/07/2529 July 2025 New | Accounts for a small company made up to 2024-12-31 |
26/05/2526 May 2025 | Confirmation statement made on 2025-04-30 with updates |
26/05/2526 May 2025 | Statement of capital following an allotment of shares on 2024-09-11 |
26/05/2526 May 2025 | Statement of capital following an allotment of shares on 2025-04-18 |
29/07/2429 July 2024 | Accounts for a small company made up to 2023-12-31 |
More Company Information
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company